Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen has reiterated an Overweight rating on Merck & Co (NYSE:MRK) and maintained a price target of $135.

February 05, 2024 | 4:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald reaffirms an Overweight rating on Merck & Co, with a steady price target of $135.
The reiteration of an Overweight rating and the maintenance of a $135 price target by a reputable analyst firm like Cantor Fitzgerald could instill confidence among investors about Merck & Co's future prospects. This positive endorsement is likely to influence investor sentiment positively in the short term, potentially leading to an uptick in MRK's stock price.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90